GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Gopro Inc. (GPRO) [hlAlert]

Rating:
Buy GPRO
down 25.24 %

Gen-probe Incorporated (GPRO) rated Buy with price target $71 by Deutsche Securities

Posted on: Tuesday,  Apr 29, 2008  12:25 PM ET by Deutsche Securities

Deutsche Securities rated Buy Gopro Inc. (NASDAQ: GPRO) on 04/29/2008. Previously Deutsche Securities rated Buy Gopro Inc. (NASDAQ: GPRO) on 11/15/2007.,
when the stock price was $63.89. Since then, Gopro Inc. has lost 25.25% as of 01/14/2016's recent price of $47.76.
If you would have followed the previous Deutsche Securities's recommendation on GPRO, you would have lost 25.24% of your investment in 2982 days.

Gen-Probe Inc. is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid testing (NAT) products used for the clinical diagnosis of human diseases and for screening donated human blood. Using its patented NAT technology, Gen-Probe has received FDA approvals for more than 40 products that detect a wide variety of infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, pneumonia and fungal infections.

Deutsche Bank's award-winning Research team manages a range of functions from asset allocation, through economic forecasting across a broad range of industry sectors including cement and construction, chemicals, electronics, energy, engineering, machinery, media, software, tobacco, retailing and utilities, and oil and gas.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/29/2008 12:25 PM Buy
None
56.47 71.00
as of 12/24/2008
1 Week down  -3.53 %
1 Month up  2.49 %
3 Months up  12.57 %
1 YTD up  6.37 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/14/2008 1:25 PM Buy
None
54.04 67.00
11/15/2007 9:25 AM Buy
None
63.89 78.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy